INVESTOR ALERT: Wites & Kapetan Announces Investigation of Omnicell

PRINCETON, N.J., March 5, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Wites & Kapetan, P.A. ( has been investigating Omnicell, Inc. ("Omnicell" or the "Company") for potential violations of the federal securities laws. Investors who purchased Omnicell common stock may be affected.

On March 2, 2015 after the market closed, Omnicell filed a Notification of Late Filing with the Securities and Exchange Commission ("SEC") stating that it will delay the filing of its Form 10-K with the SEC for the year ended December 31, 2014 in order to investigate a notice received on February 27, 2015 from a Company employee alleging, among other matters, the existence of a "side letter" arrangement with a Company customer for certain discounts and Company products that were to be provided at no cost, but which were not reflected in the final invoices paid by the customer.

On March 3, 2015, the price of Omnicell common stock declined by $2.14 per share, more than 6%, to close at $33.08 per share.

The Law Offices of Wites & Kapetan, P.A. seeks to uncover additional information about this substantial loss of shareholder value, and potential investor claims against Omnicell.

If you are an investor who purchased Omnicell stock you may have a legal claim against the Company and could serve as the lead plaintiff in a class action lawsuit. If you are interested in being the lead plaintiff, or would like to speak with an attorney about your legal rights, contact Marc A. Wites and Angela L. Dazzio-Martinez at Wites & Kapetan, P.A., at 1-866-277-8631 or

Wites & Kapetan, P.A. is a law firm with offices in New Jersey and Florida, with experience in the representation of investors in class actions, securities fraud and investor litigation claims.

Source:Law Offices of Wites & Kapetan, P.A.